Ask a new question


ME/CFSCerebral PalsyParkinson'sLong CovidMultiple SclerosisMCASCystic FibrosisStrokeEpilepsyEndometriosisMigraineALSLupus
TreatmentsLists
Most popular ways to manage stiffness, pain, and rigidity in Parkinson'sBest treatments to boost energy and motivation in Parkinson's10 non-medication based treatments for Parkinson's
Download community app

Ask a new question


ME/CFSCerebral PalsyParkinson'sLong CovidMultiple SclerosisMCASCystic FibrosisStrokeEpilepsyEndometriosisMigraineALSLupus
TreatmentsLists
Most popular ways to manage stiffness, pain, and rigidity in Parkinson'sBest treatments to boost energy and motivation in Parkinson's10 non-medication based treatments for Parkinson's
Download community app
Parkinsons/Q&A/How Many Diagnosed Each Year

How many people are diagnosed with Parkinson's disease each year?

last updated Sat, 25 Jan 2025curated by Turnto community
0:00
1x0:00
5 Research papers
3 Expert views
12 Resources

The basics

Each year, nearly 90,000 people in the United States are diagnosed with Parkinson's disease. This figure represents a significant increase from previous estimates, which were around 60,000 diagnoses annually. Globally, more than 10 million people are living with Parkinson's disease. These statistics highlight the growing prevalence of this neurodegenerative disorder, which is the second most common after Alzheimer's disease.

Understanding Parkinson's Disease Diagnosis

Annual Diagnosis Rates

  • United States: Approximately 90,000 new cases are diagnosed each year.
  • Global Context: Over 10 million people worldwide are living with Parkinson's disease.

Factors Influencing Diagnosis Rates

  • Aging Population: As the global population ages, the incidence of Parkinson's disease is expected to rise.
  • Improved Awareness and Diagnosis: Advances in medical technology and increased awareness may contribute to higher diagnosis rates.

Implications of Rising Diagnosis Rates

  • Healthcare System Impact: The increasing number of diagnoses places a growing demand on healthcare systems for specialized care and resources.
  • Research and Funding: Higher incidence rates underscore the need for continued research and funding to develop better treatments and potentially find a cure.

Understanding these statistics is crucial for planning healthcare resources and supporting ongoing research efforts to combat Parkinson's disease.


What the research says

5 Research papers

Research has shown that the incidence of Parkinson's disease varies significantly across different regions and populations. Understanding these variations is crucial for healthcare planning and resource allocation.

Research trends

The study of Parkinson's disease incidence is a well-researched area, with numerous studies conducted globally to understand its epidemiology. The incidence rates are often reported per 100,000 person-years, and these rates can vary based on factors such as age, gender, and ethnicity. Recent research highlights the increasing prevalence of Parkinson's disease, particularly in high-income countries, due to factors like aging populations and improved diagnostic capabilities12.

Key findings found in select papers

  1. Global Incidence Rates:

    • A study using the Global Burden of Disease database found that the global incidence rate for Parkinson's disease in 2021 was approximately 79.68 cases per 100,000 population, with higher rates in high-middle sociodemographic index regions4.
  2. Regional Variations:

    • In Germany, a study reported a decline in the incidence of idiopathic Parkinson's disease from 137 to 106 new cases per 100,000 persons between 2013 and 20193.
    • In the UK, the incidence rate remained stable at around 144 per 100,000 person-years from 2006 to 20162.
  3. Local Studies:

    • In the Canton of Geneva, Switzerland, the age-adjusted average annual incidence of Parkinson's disease was found to be 20 per 100,000 per year5.

Unknowns and mixed opinions

  1. Environmental and Genetic Factors:

    • There is ongoing debate about the role of environmental factors, such as exposure to neurotoxic agents, and genetic predispositions in the incidence of Parkinson's disease1.
  2. Data Limitations:

    • Some regions, particularly low-income countries, lack high-quality data, making it challenging to accurately assess incidence rates and trends1.
  3. Impact of Healthcare Access:

    • Differences in healthcare access and diagnostic practices can lead to variations in reported incidence rates, complicating comparisons across regions1.

Overall, while there is a wealth of research on Parkinson's disease incidence, variations in data quality and regional differences highlight the need for continued study and international collaboration to better understand and address this growing health concern.

Research

This paper investigates the epidemiology of Parkinson's disease, highlighting variations in prevalence and incidence across different demographics and regions. The study emphasizes the role of genetic and environmental factors in the disease's development and the need for comprehensive prevention strategies.

Key findings include the observation that Parkinson's disease is more common in older individuals and men, with potential environmental factors like neurotoxic agents contributing to its prevalence. The study also notes ethnic differences in disease risk, possibly due to healthcare access disparities.

For those living with or caring for someone with Parkinson's disease, this research underscores the importance of understanding the multifactorial causes of the disease, which can inform prevention and management strategies.

The paper is published in a reputable journal, Lancet, and provides a thorough analysis of Parkinson's disease epidemiology, making it a reliable source for understanding the disease's global impact.

January 2024 • Lancet (London, England)

Research

This cohort study examines the incidence of Parkinson's disease in the UK from 2006 to 2016, using a large primary care database. The study aims to determine if the incidence has changed over time, accounting for age and diagnostic patterns.

The key finding is that the incidence of Parkinson's disease remained stable during the study period, suggesting no major changes in underlying risk factors. The incidence rate was approximately 144 per 100,000 person-years in 2016.

For individuals affected by Parkinson's disease, this study provides reassurance that the incidence has not increased, indicating stable risk factors over the decade.

The study is published in NPJ Parkinson's disease, a specialized journal, and uses robust data from a large UK database, making it a reliable source for understanding Parkinson's disease trends in the UK.

March 2022 • NPJ Parkinson's disease


What the experts say

3 Expert views

Each year, approximately 60,000 people are diagnosed with Parkinson's disease in the United States. This statistic highlights Parkinson's as one of the most common brain diseases, second only to Alzheimer's1. The incidence of Parkinson's disease varies globally, with factors such as aging populations and environmental exposures contributing to the number of new cases23.

Global Trends

  • The number of people with Parkinson's disease is expected to double by 2040, reaching over 12 million worldwide. This increase is attributed to industrialization and environmental factors, particularly in countries like China3.
  • Younger onset Parkinson's disease (YOPD) is often underreported, and the aging population contributes significantly to the rising number of cases2.

These insights underscore the importance of understanding the factors influencing Parkinson's disease diagnosis rates and the need for updated statistics to reflect these changes.

Video

Dr. Rachel Dolhun from The Michael J. Fox Foundation explains that in the United States, approximately 60,000 people are diagnosed with Parkinson's disease each year. This statistic highlights Parkinson's as one of the most common brain diseases, second only to Alzheimer's. The average age of diagnosis is 60, and the risk increases with age.

August 2017 • The Michael J. Fox Foundation for Parkinson's Research

Video

Hugh Johnston discusses the changing statistics of Parkinson's disease, noting that the incidence rates vary by country. He highlights that the aging population contributes to the increasing number of cases, and that younger onset Parkinson's disease (YOPD) is often underreported. The webinar emphasizes the need for updated statistics to reflect these changes.

April 2020 • Cure Parkinson's


Related resources

12 Resources
Approximately 90,000 people in the U.S. are diagnosed with Parkinson's annually.

Approximately 90,000 people in the U.S. are diagnosed with Parkinson's annually.

Parkinson's Foundation

Podcast discusses Parkinson's impact, with 90,000 new US diagnoses annually.

Podcast discusses Parkinson's impact, with 90,000 new US diagnoses annually.

April 15, 2024 • Growing Older Living Younger

Video on Parkinson's disease prevalence and causes.

YouTube

Parkinson's Foundation Helpline offers support and information.

Parkinson's Foundation Helpline offers support and information.

Parkinson's Foundation

Parkinson's UK offers resources for patients and caregivers.

Parkinson's UK offers resources for patients and caregivers.

Parkinson's UK

Michael J. Fox Foundation offers resources for newly diagnosed patients.

Michael J. Fox Foundation offers resources for newly diagnosed patients.

Michael J. Fox Foundation

Personal stories from the Parkinson's community.

Personal stories from the Parkinson's community.

Parkinson's Foundation

Mayo Clinic's guide on Parkinson's diagnosis and treatment.

September 27, 2024 • Mayo Clinic

APDA offers local resources and support for Parkinson's patients.

APDA offers local resources and support for Parkinson's patients.

2024 • American Parkinson Disease Association

Parkinson's Foundation provides resources and research updates.

Parkinson's Foundation provides resources and research updates.

Parkinson's Foundation

APDA supports Parkinson's patients with resources and research.

APDA supports Parkinson's patients with resources and research.

December 19, 2024 • American Parkinson Disease Association

Michael J. Fox Foundation focuses on Parkinson's research and support.

Michael J. Fox Foundation focuses on Parkinson's research and support.

Michael J. Fox Foundation

Was this helpful?

This is not healthcare advice or a recommendation. This tool is in beta and currently experimental. It is designed to help you find the most recent and helpful sources, from different voices, for you to take to consider with your healthcare team.

We appreciate any feedback as we aim to help speed up breakthroughs for all conditions.


Related questions
What are the early symptoms of Parkinson's disease?
How is Parkinson's disease diagnosed?
What are the risk factors for Parkinson's disease?
What treatments are available for Parkinson's disease?
How does Parkinson's disease progress over time?

Explore more lists

More lists
Most popular ways to manage stiffness, pain, and rigidity in Parkinson's
Community list

Most popular ways to manage stiffness, pain, and rigidity in Parkinson's

229 experts
327 patients

Curated by Crowd
Verified by Turnto
Best treatments to boost energy and motivation in Parkinson's
Community list

Best treatments to boost energy and motivation in Parkinson's

217 experts
273 patients

Curated by Crowd
Verified by Turnto
More lists
Turn on alertsNext in 0m
Get everything related to you in one easy update.

TermsPrivacyDisclaimerContact

© 2026 Turnto

Stay up to date on ParkinsonsGet everything Parkinsons general related to you in one easy update.Try for free
Turny found you 16 things (Physiotherapy, New medications)
Turny (with Turnto) 2 mins ago
to me